Cargando…
Use of methotrexate and risk of skin cancer: a nationwide case–control study
BACKGROUND: Methotrexate (MTX) use has been suspected of increasing the risk of skin cancer. The aim of this investigation was to examine the association between the use of MTX and the risk of basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC) and cutaneous malignant melanoma (CMM)...
Autores principales: | Polesie, Sam, Gillstedt, Martin, Schmidt, Sigrún Alba Jóhannesdóttir, Egeberg, Alexander, Pottegård, Anton, Kristensen, Kasper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050200/ https://www.ncbi.nlm.nih.gov/pubmed/36739322 http://dx.doi.org/10.1038/s41416-023-02172-7 |
Ejemplares similares
-
Methotrexate Use for Patients with Psoriasis and Risk of Cutaneous Squamous Cell Carcinoma: A Nested Case-control Study
por: GIANNOPOULOS, Filippos, et al.
Publicado: (2021) -
Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control study
por: Pottegård, Anton, et al.
Publicado: (2019) -
Flecainide and risk of skin neoplasms: Results of a large nested case–control study in Spain and Denmark
por: Reyes, Carlen, et al.
Publicado: (2022) -
Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma
por: Pottegård, Anton, et al.
Publicado: (2018) -
Ability to Predict Melanoma Within 5 Years Using Registry Data and a Convolutional Neural Network: A Proof of Concept Study
por: GILLSTEDT, Martin, et al.
Publicado: (2022)